Table 4.

Baseline characteristic and mortality outcome measures. Categorical variables are presented as counts (%), and continuous variables are presented as medians [inter-quartile range Q1-Q3]

	Overall	Died in the hospital	Survived in the hospital
General
Admissions	6927	1350	5577
Age	65.0 [53.0,77.0]	71.0 [58.0,81.0]	64.0 [52.0,75.0]
Gender (Female)	2853 (41.2%)	602 (44.6%)	2251 (40.4%)
First SOFA	6.0 [4.0,8.0]	8.0 [5.0,11.0]	5.0 [4.0,8.0]
First SAPS	21.0 [18.0,25.0]	24.0 [21.0,28.0]	21.0 [18.0,24.0]
First SAPS II	41.0 [32.0,52.0]	53.0 [44.0,64.0]	39.0 [31.0,49.0]
Origin
Elective	1269 (18.3%)	64 (4.7%)	1205 (21.6%)
Emergency	5463 (78.9%)	1237 (91.6%)	4226 (75.8%)
Urgent	195 (2.8%)	49 (3.6%)	146 (2.6%)
Site
MICU	1974 (28.5%)	600 (44.4%)	1374 (24.6%)
SICU	1359 (19.6%)	266 (19.7%)	1093 (19.6%)
CCU	660 (9.5%)	163 (12.1%)	497 (8.9%)
CSRU	1599 (23.1%)	98 (7.3%)	1501 (26.9%)
TSICU	1335 (19.3%)	223 (16.5%)	1112 (19.9%)
Lab Results
HR (BPM)	88.0 [76.0,102.0]	92.0 [78.0,109.0]	87.0 [76.0,100.0]
NBP (MMHG)	113.0 [100.0,130.0]	109.0 [95.0,127.0]	114.0 [101.0,129.0]
RR (CPM)	20.56 [17.71-23.88]	20.78 [17.90-24.19]	20.31 [17.57-23.53]
NA (MMOL/L)	139.0 [137.0,142.0]	140.0 [136.0,143.0]	139.0 [137.0,142.0]
K (MMOL/L)	4.1 [3.8,4.6]	4.2 [3.7,4.7]	4.1 [3.8,4.6]
HCO3 (MMOL/L)	23.0 [19.0,25.0]	21.0 [17.0,24.0]	23.0 [20.0,26.0]
WBC (103/MM3)	11.7 [8.2,16.1]	12.3 [7.5,17.8]	11.7 [8.4,15.8]
P/F Ratio	235.13 [227.10-235.13]	235.13 [207.50-235.23]	235.13 [235.13-235.13]
Ht (%)	28.40 [25.00-32.30]	27.90 [24.40-31.70]	29.10 [25.80-32.70]
Urea (mmol/l)	77.79 [46.35-120.52]	70.27 [34.77-94.43]	104.25 [60.69-140.53]
Bilirubin (mg/dl)	1.00 [0.50-2.36]	1.25 [0.50-2.88]	0.88 [0.45-1.66]
Outcomes
ICU LOS (days)	4.7 [2.4,10.5]	5.7 [2.7,11.7]	4.5 [2.3,10.2]
ICU Death (%)	1129 (16.3%)	1129 (83.6%)	-
Hospital Death (%)	1350 (19.5%)	1350 (100%)	-